IRONWOOD PHARMACEUTICALS, INC. Hedging Liabilities, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Hedging Liabilities, Current of $19.00 thousand as of 2022-12-31, per its 10-K filed 2024-02-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:HedgingLiabilitiesCurrent · last filed 2024-02-16
- 2022-12-31: Hedging Liabilities, Current $19.00K.
- 2022-09-30: Hedging Liabilities, Current $1.00K.
- 2022-06-30: Hedging Liabilities, Current $152.00K.
- 2022-03-31: Hedging Liabilities, Current $899.00K.
| Period end | Hedging Liabilities, Current |
|---|---|
| 2022-12-31 | $19.00K 10-K · filed 2024-02-16 |
| 2022-09-30 | $1.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $152.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $899.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.32M 10-K · filed 2023-02-16 |
| 2021-09-30 | $5.49M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |